Latest Insider Transactions at Azenta, Inc. (AZTA)
This section provides a real-time view of insider transactions for Azenta, Inc. (AZTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Azenta, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Azenta, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2023
|
David C Gray Chief Strategy & New Business |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,179
-6.47%
|
$279,666
$54.83 P/Share
|
|
Nov 16
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,779
-2.24%
|
$147,287
$53.81 P/Share
|
|
Nov 16
2023
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,448
+4.79%
|
$1,212,192
$54.57 P/Share
|
|
Nov 16
2023
|
Stephen S Schwartz CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,865
-2.94%
|
$681,845
$53.81 P/Share
|
|
Nov 16
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
4,582
+12.89%
|
$247,428
$54.57 P/Share
|
|
Nov 16
2023
|
Robin Vacha SVP, GM Life Science Products |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,946
-10.05%
|
$156,138
$53.81 P/Share
|
|
Nov 16
2023
|
David Dong Wang SVP & GM, SMS |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+25.01%
|
$173,178
$54.57 P/Share
|
|
Nov 16
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+20.43%
|
$173,178
$54.57 P/Share
|
|
Nov 16
2023
|
Ginger Zhou SVP and General Manager, Genom |
SELL
Sale (or disposition) back to the issuer
|
Direct |
458
-4.7%
|
$24,274
$53.81 P/Share
|
|
Nov 16
2023
|
Herman Cueto EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,890
+44.05%
|
$804,060
$54.57 P/Share
|
|
Nov 16
2023
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
2,291
+2.78%
|
$123,714
$54.57 P/Share
|
|
Nov 16
2023
|
David C Gray Chief Strategy & New Business |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,161
-2.7%
|
$114,533
$53.81 P/Share
|
|
Nov 16
2023
|
Violetta Hughes VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,374
+25.3%
|
$74,196
$54.57 P/Share
|
|
Nov 16
2023
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
5,498
+4.89%
|
$296,892
$54.57 P/Share
|
|
Nov 16
2023
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,831
-1.77%
|
$97,043
$53.81 P/Share
|
|
Nov 16
2023
|
Olga Pirogova SVP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
3,207
+50.0%
|
$173,178
$54.57 P/Share
|
|
Nov 15
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,297
+4.84%
|
$340,038
$54.13 P/Share
|
|
Nov 15
2023
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,426
+3.62%
|
$887,004
$54.13 P/Share
|
|
Nov 15
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
4,107
+12.28%
|
$221,778
$54.13 P/Share
|
|
Nov 15
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
877
+8.26%
|
$47,358
$54.13 P/Share
|
|
Nov 15
2023
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+3.47%
|
$155,250
$54.13 P/Share
|
|
Nov 15
2023
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
3,559
+3.33%
|
$192,186
$54.13 P/Share
|
|
Aug 11
2023
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
10,877
-12.37%
|
$609,112
$56.03 P/Share
|
|
Aug 10
2023
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
4,311
-4.67%
|
$245,727
$57.24 P/Share
|
|
Aug 10
2023
|
Robin Vacha SVP, GM Life Science Products |
SELL
Grant, award, or other acquisition
|
Direct |
7,400
-22.69%
|
$407,000
$55.0 P/Share
|
|
Aug 08
2023
|
Ellen M Zane Director |
SELL
Grant, award, or other acquisition
|
Direct |
18,766
-31.33%
|
$1,032,130
$55.78 P/Share
|
|
Jul 31
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105
+0.09%
|
$4,095
$39.98 P/Share
|
|
Jul 31
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
54
+0.61%
|
$2,106
$39.98 P/Share
|
|
Jul 31
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
121
+0.37%
|
$4,719
$39.98 P/Share
|
|
Jun 06
2023
|
Joseph R Martin Director |
SELL
Open market or private sale
|
Direct |
2,400
-2.74%
|
$103,200
$43.07 P/Share
|
|
Feb 13
2023
|
Dorothy E Puhy Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+50.0%
|
-
|
|
Feb 13
2023
|
Michael Rosenblatt |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+25.41%
|
-
|
|
Feb 13
2023
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+5.68%
|
-
|
|
Feb 13
2023
|
Frank Casal |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+38.37%
|
-
|
|
Feb 13
2023
|
Robyn C Davis |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+11.73%
|
-
|
|
Feb 13
2023
|
Joseph R Martin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,268
+5.36%
|
-
|
|
Feb 13
2023
|
Erica Mc Laughlin |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+25.82%
|
-
|
|
Feb 13
2023
|
Tina Susan Nova |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+50.0%
|
-
|
|
Feb 13
2023
|
Krishna G. Palepu Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,604
+3.31%
|
-
|
|
Jan 31
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
323
+3.54%
|
$14,858
$46.92 P/Share
|
|
Jan 31
2023
|
Kimberly Crowley SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
177
+2.34%
|
$8,142
$46.92 P/Share
|
|
Jan 31
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
279
+0.24%
|
$12,834
$46.92 P/Share
|
|
Jan 31
2023
|
Vandana Sriram SVP Finance & Corp. Controller |
BUY
Grant, award, or other acquisition
|
Direct |
369
+5.49%
|
$16,974
$46.92 P/Share
|
|
Jan 31
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
265
+0.81%
|
$12,190
$46.92 P/Share
|
|
Nov 17
2022
|
Kimberly Crowley SVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,519
+25.86%
|
-
|
|
Nov 17
2022
|
David C Gray Chief Strategy & New Business |
BUY
Grant, award, or other acquisition
|
Direct |
3,148
+3.3%
|
-
|
|
Nov 17
2022
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
3,778
+3.65%
|
-
|
|
Nov 17
2022
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,296
+5.1%
|
-
|
|
Nov 17
2022
|
Stephen S Schwartz CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,886
+4.3%
|
-
|
|
Nov 17
2022
|
Vandana Sriram SVP Finance & Corp. Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,519
+29.61%
|
-
|